Cargando…
Pharmacogenomics in clinical trials: an overview
With the trend towards promoting personalised medicine (PM), the application of pharmacogenetics and pharmacogenomics (PGx) is of growing importance. For the purposes of clinical trials, the inclusion of PGx is an additional tool that should be considered for improving our knowledge about the effect...
Autor principal: | Nogueiras-Álvarez, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625420/ https://www.ncbi.nlm.nih.gov/pubmed/37927590 http://dx.doi.org/10.3389/fphar.2023.1247088 |
Ejemplares similares
-
Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023) -
Current clinical evidence on pioglitazone pharmacogenomics
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2013) -
Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012) -
Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014) -
Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)